1Debes-Marum CS, Dewald GW, Bryant S, et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia, 2003 ; 17:427 - 436
2Lai JL, Zandecki M, Mary JY, et al. Improved cytogenetics in multiple myeloma:a study of 151 patients including 117 patients at diagnosis. Blood, 1995 ; 85:2490 - 2497
3Harrison C J, Mazzullo H, Cheung KL, et al. Cytogenetics of multiple myeloma:interpretation of fluorescence in situ hybridization resuits. Br J Haematol, 2003; 120:944 -952
4Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood, 2002; 99:2185-2191
5Zojer N, Konigskerg R, Ackermann J, etal. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood, 2000; 95: 1925- 1930
